Soft chewy confection comprising hmo
US-2024000098-A1 · Jan 4, 2024 · US
US9854826B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9854826-B2 |
| Application number | US-201113988984-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 21, 2011 |
| Priority date | Nov 23, 2010 |
| Publication date | Jan 2, 2018 |
| Grant date | Jan 2, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention discloses an oligosaccharide mixture comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide. Food product, especially infant formula, comprising said oligosaccharide mixture.
Opening claim text (preview).
The invention claimed is: 1. A method for reducing the risk of and/or reducing the severity of and/or reducing the occurrence of food allergies and related food allergy effects on health selected from the group consisting of (i) skin effects, atopic dermatitis, rash, and redness; (ii) effects on the immune system and inflammation status; and (iii) effects on the gastro-intestinal system, the method comprising: administering to an infant or young child in need of same a food product comprising about 0.2 to about 5 grams of an oligosaccharide mixture per liter of the food product, the oligosaccharide mixture consisting of equal parts of lacto-N-neotetraose, 6′-sialyllactose, and 2′-fucosyllactose. 2. A method for reducing the risk of and/or reducing the severity of and/or reducing the occurrence of food allergies and related food allergy effects on health selected from the group consisting of (i) skin effects, atopic dermatitis, rash, and redness; (ii) effects on the immune system and inflammation status; and (iii) effects on the gastro-intestinal system, the method comprising: administering to an infant or young child in need of same a food product comprising about 0.2 to about 5 grams of an oligosaccharide mixture per liter of the food product, the oligosaccharide mixture consisting of equal parts of lacto-N-neotetraose, 6′-sialyllactose, and 2′-fucosyllactose, as a synthetic nutritional composition. 3. A method for the enhancement of the oral tolerance to allergens, the method comprising: administering, to an infant or young child who has experienced at least one episode of an allergy selected from the group consisting of a respiratory allergy and a skin allergy, a food product comprising about 0.2 to about 5 grams of an oligosaccharide mixture per liter of the food product, the oligosaccharide mixture consisting of equal parts of lacto-N-neotetraose, 6′-sialyllactose, and 2′-fucosyllactose, as a synthetic nutritional composition. 4. The method of claim 2 , wherein the food product is a supplement. 5. The method of claim 1 , wherein the food product comprises Bifidobacterium longum and hydrolyzed proteins. 6. The method of claim 2 , wherein the food product comprises Bifidobacterium longum and hydrolyzed proteins. 7. The method of claim 3 , wherein the food product comprises Bifidobacterium longum and hydrolyzed proteins. 8. The method of claim 1 , wherein the food product comprises a fat source that has a ratio of n-6 to n-3 fatty acids of about 8:1 to 10:1. 9. The method of claim 2 , wherein the food product comprises a fat source that has a ratio of n-6 to n-3 fatty acids of about 8:1 to 10:1. 10. The method of claim 3 , wherein the food product comprises a fat source that has a ratio of n-6 to n-3 fatty acids of about 8:1 to 10:1.
Immunomodulators · CPC title
Drugs for immunological or allergic disorders · CPC title
Drugs for dermatological disorders · CPC title
Addition of substantially indigestible substances, e.g. dietary fibres · CPC title
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.